IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial (Q34795777)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial |
scientific article |
Statements
1 reference
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial (English)
1 reference
R van Vollenhoven
1 reference
E Keystone
1 reference
H P Tony
1 reference
A Cantagrel
1 reference
A Sanchez
1 reference
E Alecock
1 reference
J Lee
1 reference
J Kremer
1 reference
14 July 2008
1 reference
1 reference
67
1 reference
11
1 reference
1516-1523
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference